AUTHOR=Zhong Xiaodan , Liu Yuanning , Liu Haiming , Zhang Yutong , Wang Linyu , Zhang Hao 

TITLE=Identification of Potential Prognostic Genes for Neuroblastoma

JOURNAL=Frontiers in Genetics

VOLUME=9

YEAR=2018

URL=https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2018.00589

DOI=10.3389/fgene.2018.00589

ISSN=1664-8021

ABSTRACT=<p><bold>Background and Objective:</bold> Neuroblastoma (NB), the most common pediatric solid tumor apart from brain tumor, is associated with dismal long-term survival. The aim of this study was to identify a gene signature to predict the prognosis of NB patients.</p><p><bold>Materials and Methods:</bold> GSE49710 dataset from the Gene Expression Omnibus (GEO) database was downloaded and differentially expressed genes (DEGs) were analyzed using R package “limma” and SPSS software. The gene ontology (GO) and pathway enrichment analysis were established via DAVID database. Random forest (RF) and risk score model were used to pick out the gene signature in predicting the prognosis of NB patients. Simultaneously, the receiving operating characteristic (ROC) and Kaplan-Meier curve were plotted. GSE45480 and GSE16476 datasets were employed to validate the robustness of the gene signature.</p><p><bold>Results:</bold> A total of 131 DEGs were identified, which were mainly enriched in cancer-related pathways. Four genes (<italic>ERCC6L</italic>, <italic>AHCY</italic>, <italic>STK33</italic>, and <italic>NCAN</italic>) were selected as a gene signature, which was included in the top six important features in RF model, to predict the prognosis in NB patients, its area under the curve (AUC) could reach 0.86, and Cox regression analysis revealed that the 4-gene signature was an independent prognostic factor of overall survival and event-free survival. As well as in GSE16476. Additionally, the robustness of discriminating different groups of the 4-gene signature was verified to have a commendable performance in GSE45480 and GSE49710.</p><p><bold>Conclusion:</bold> The present study identified a gene-signature in predicting the prognosis in NB, which may provide novel prognostic markers, and some of the genes may be as treatment targets according to biological experiments in the future.</p>